Strategies to advance translational research into brain barriers (Q37037950)

17 August 2017

1 reference

title

Strategies to advance translational research into brain barriers (English)

1 reference

17 August 2017

11

1 reference

17 August 2017

9

Maiken Nedergaard

0 references

Britta Engelhardt

object named as

Britta Engelhardt

7

0 references

Thomas P. Davis

object named as

Thomas Davis

6

0 references

John G Nutt

10

object named as

John Nutt

1 reference

17 August 2017

1

Edward Neuwelt

1 reference

17 August 2017

3

Lauren Abrey

1 reference

17 August 2017

N Joan Abbott

2

1 reference

17 August 2017

William A Banks

4

1 reference

17 August 2017

Brian Blakley

5

1 reference

17 August 2017

Paula Grammas

8

1 reference

17 August 2017

Gary A Rosenberg

12

1 reference

17 August 2017

Quentin Smith

13

1 reference

17 August 2017

Lester R Drewes

14

1 reference

17 August 2017

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

84-96

1 reference

17 August 2017

1

1 reference

The blood-brain barrier/neurovascular unit in health and disease

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The expression and function of chemokines involved in CNS inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Blood-brain barrier transport of cytokines: a mechanism for neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The blood-brain barrier in neuroAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The relationship between plasma protein extravasation and remote tissue changes after experimental brain infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Neuroprotection in experimental stroke with targeted neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

BDNF plasma levels in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal neurons against ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Multiple roles for MMPs and TIMPs in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Astrocyte-endothelial interactions at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Drug penetration in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The status of gene therapy for brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Implications of the blood-brain barrier in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Efflux of human and mouse amyloid β proteins 1–40 and 1–42 from brain: impairment in a mouse model of alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Translational considerations for CNS gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Structural characteristics and barrier properties of the choroid plexuses in developing brain of the opossum (Monodelphis Domestica).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

The choroid plexus-cerebrospinal fluid system: from development to aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Molecular and physiological bases of the K+ circulation in the mammalian inner ear.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Expression patterns of claudins, tight junction adhesion molecules, in the inner ear

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Strategies to create a regenerating environment for the injured spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Blood‐spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Isolation and culture of microvascular endothelial cells from murine spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Brain-specific expression of an exogenous gene after i.v. administration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Transcytotic pathway for blood-borne protein through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970326-5

7 January 2021

10.1016/S1474-4422(07)70326-5

Identifiers

DOI

1 reference

17 August 2017

1 reference